creator Josefsson, Gustaf creator Ames, Kerry creator Calizo, Milagros creator Schiller, Brian creator Groth, Kristel creator Ervin, Natalia creator Holmes, Matt creator Lee, Hyun creator Lim, Eung creator Ravi, Iyengar AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale. Submitted by Ariel True (atrue@iit.edu) on 2011-03-22T15:54:32Z No. of bitstreams: 7 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) ACCELPharma IPRO 353 Poster F06.pdf: 13785566 bytes, checksum: 3a5bc2c88b17964af1b958a46a78dec4 (MD5) ACCELPharma IPRO 353 Midterm Presentation F06.pdf: 1841516 bytes, checksum: 9a183ee430476b619a8d337e3a0db86d (MD5) ACCELPharma IPRO 353 IPRO Day Presentation F06.pdf: 1397777 bytes, checksum: 1c884ead6a3d407659d519855864c065 (MD5) ACCELPharma IPRO 353 Final Report F06.pdf: 1895233 bytes, checksum: efe078f577f30c8f3cafebcbf4e9d3df (MD5) ACCELPharma IPRO 353 Abstract F06.pdf: 3325949 bytes, checksum: 0ff06bbe9451303eabf52625e03e9157 (MD5) Approved for entry into archive by Charles Uth(uth@iit.edu) on 2011-03-23T13:06:43Z (GMT) No. of bitstreams: 7 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) ACCELPharma IPRO 353 Poster F06.pdf: 13785566 bytes, checksum: 3a5bc2c88b17964af1b958a46a78dec4 (MD5) ACCELPharma IPRO 353 Midterm Presentation F06.pdf: 1841516 bytes, checksum: 9a183ee430476b619a8d337e3a0db86d (MD5) ACCELPharma IPRO 353 IPRO Day Presentation F06.pdf: 1397777 bytes, checksum: 1c884ead6a3d407659d519855864c065 (MD5) ACCELPharma IPRO 353 Final Report F06.pdf: 1895233 bytes, checksum: efe078f577f30c8f3cafebcbf4e9d3df (MD5) ACCELPharma IPRO 353 Abstract F06.pdf: 3325949 bytes, checksum: 0ff06bbe9451303eabf52625e03e9157 (MD5) Made available in DSpace on 2011-03-23T13:06:43Z (GMT). No. of bitstreams: 7 license_rdf: 22564 bytes, checksum: ff373f1ad387898ef8ba4f8bc9e37073 (MD5) license_text: 20904 bytes, checksum: e09bf99e64678e4285abf3ef3e05412d (MD5) ACCELPharma IPRO 353 Poster F06.pdf: 13785566 bytes, checksum: 3a5bc2c88b17964af1b958a46a78dec4 (MD5) ACCELPharma IPRO 353 Midterm Presentation F06.pdf: 1841516 bytes, checksum: 9a183ee430476b619a8d337e3a0db86d (MD5) ACCELPharma IPRO 353 IPRO Day Presentation F06.pdf: 1397777 bytes, checksum: 1c884ead6a3d407659d519855864c065 (MD5) ACCELPharma IPRO 353 Final Report F06.pdf: 1895233 bytes, checksum: efe078f577f30c8f3cafebcbf4e9d3df (MD5) ACCELPharma IPRO 353 Abstract F06.pdf: 3325949 bytes, checksum: 0ff06bbe9451303eabf52625e03e9157 (MD5) Previous issue date: 2006-12 Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester. 2006-12 2006-12 http://hdl.handle.net/10560/1607 en Gary Reznik Jon Liao Pharmaceuticals Project deliverable born digital application/pdf In Copyright http://rightsstatements.org/page/InC/1.0/ Open Access IPRO / Interprofessional Projects Program Illinois Institute of Technology Affiliated department